Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Net Income towards Common Stockholders: 2020-2025

Historic Net Income towards Common Stockholders for Roivant Sciences (ROIV) over the last 5 years, with Sep 2025 value amounting to -$166.0 million.

  • Roivant Sciences' Net Income towards Common Stockholders fell 285.39% to -$166.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$156.0 million, marking a year-over-year decrease of 64.01%. This contributed to the annual value of $373.2 million for FY2025, which is 218.42% up from last year.
  • As of Q3 2025, Roivant Sciences' Net Income towards Common Stockholders stood at -$166.0 million, which was up 39.38% from -$273.9 million recorded in Q2 2025.
  • Roivant Sciences' 5-year Net Income towards Common Stockholders high stood at $327.0 million for Q4 2024, and its period low was -$384.9 million during Q4 2022.
  • Over the past 3 years, Roivant Sciences' median Net Income towards Common Stockholders value was -$70.6 million (recorded in 2023), while the average stood at -$67.0 million.
  • Per our database at Business Quant, Roivant Sciences' Net Income towards Common Stockholders crashed by 1,167.12% in 2021 and then spiked by 658.87% in 2024.
  • Roivant Sciences' Net Income towards Common Stockholders (Quarterly) stood at -$306.1 million in 2021, then decreased by 25.75% to -$384.9 million in 2022, then soared by 84.80% to -$58.5 million in 2023, then surged by 658.87% to $327.0 million in 2024, then tumbled by 285.39% to -$166.0 million in 2025.
  • Its last three reported values are -$166.0 million in Q3 2025, -$273.9 million for Q2 2025, and $327.0 million during Q4 2024.